201Tl scintigraphy for patients before 131I therapy-comparison with the 131I accumulation and the therapeutic effect

Japanese Journal of Clinical Radiology

Volumn 48, Issue 9, 2003, Pages 1087-1095

  Okuyama, C ^a   Ushijima, Y ^a   Kubota, T ^a   Nakai, T ^a   Kobayashi, K ^a   Tsubokura, T ^a   Nishimura, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THALLIUM 201;

ARTICLE; CLINICAL ARTICLE; HUMAN; METASTASIS; RADIODIAGNOSIS; SCINTIGRAPHY; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

EID: 0141815668     PISSN: 00099252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Seidlin SM et al: Radioactive iodine therapy. JAMA 132: 838-847, 1946
2. Pacini F et al: Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28: 1888-1891, 1987
3. Carril JM et al: Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer. J Nucl Med 38: 686-692, 1997
4. Nakada K et al: Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma. J Nucl Med 39: 807-810, 1998
5. 131I whole-body scan. J Nucl Med 40: 986-992, 1999
6. Dietlein M et al: Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24: 1342-1348, 1997